Skip to main content
Log in

First pass hydroxylation of nortriptyline: Concentrations of parent drug and major metabolites in plasma

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Nortriptyline was given orally and intramuscularly to six depressed patients. Plasma concentrations of parent drug and the unconjugated and conjugated principal metabolite, 10-hydroxynortriptyline, were determined by mass fragmentography. There was a significant decrease in the area under the nortriptyline plasma concentration — time curve after the oral route of administration, whilst the elimination rate was unchanged. With the oral dose, plasma concentrations of the metabolites were higher and peaked earlier than after intramuscular administration, whilst the opposite was true for the parent compound. This proves that the difference in bioavailability between the two routes of administration was due to first pass metabolism. As determined from the ratio between corresponding areas, the relative bioavailability of the oral dose was 66±21 S.D. per cent. This fraction is higher than that reported previously when intravenous nortriptyline was used as the reference dosage form.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexanderson, B.: Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single dose plasma level data. Europ. J. clin. Pharmacol.5, 44–54 (1972)

    Google Scholar 

  2. Alexanderson, B., Borgå, O., Alván, G.: The availability of orally administered nortriptyline. Europ. J. clin. Pharmacol.5, 181–185 (1973)

    Google Scholar 

  3. Alván, G., Lind, M., Mellström, B., von Bahr, C.: Importance of “first pass elimination” for interindividual differences in equilibrium concentrations of the adrenergic beta-receptor antagonist alprenolol. J. Pharmacokin. Biopharm. Submitted

  4. Alván, G., Sjöqvist, F.: Behandling av akuta intoxikationer — farmakokinetiska behandlingsprinciper. Läkartidningen68, (suppl I) 65–78 (1971)

    Google Scholar 

  5. Borgå, O., Palmér, L., Linnarsson, A., Holmstedt, B.: Quantitative determination of nortriptyline and desmethylnortriptyline in human plasma by combined gas chromatography — mass spectrometry. Anal. Letters4, 837–849 (1971)

    Google Scholar 

  6. Borgå, O., Palmér, L., Sjöqvist, F., Holmstedt, B.: Mass fragmentography used in quantitative analysis of drugs and endogenous compounds in biological fluids. Proc. 5th Int. Congr. Pharmacology, San Francisco 1972,3, pp. 56–68. Basel: Karger 1973

    Google Scholar 

  7. Gibaldi, M.: Comparison of observed and predicted bioavailability of nortriptyline in humans following oral administration. J. pharm. Sci.64, 1036–1037 (1975)

    Google Scholar 

  8. Gibaldi, M., Boyes, R. N., Feldman, S.: Influence of first pass effect on availability of drugs on oral administration. J. pharm. Sci.60, 1338–1340 (1971)

    Google Scholar 

  9. Gram, L. F., Christiansen, J.: First-pass metabolism of imipramine in man. Clin. Pharmacol. Ther.17, 555–563 (1975)

    Google Scholar 

  10. Gram, L. F., Fredricson-Overø, K.: First-pass metabolism of nortriptyline in man. Clin. Pharmacol. Ther.18, 305–314 (1975)

    Google Scholar 

  11. Grundin, R., Moldéus, P., Orrenius, S., Borg, K. O., Skånberg, I., von Bahr, C.: The possible role of cytochrome P-450 in the liver “first pass elimination” of a β-receptor blocking drug. Acta pharmacol. (Kbh.)35, 242–260 (1974)

    Google Scholar 

  12. Hammer, W., Ideström, C. M., Sjöqvist, F.: Chemical control of antidepressant drug therapy. In: Proc. First Internat. Symposium on Antidepressant Drugs, Milan 1966 (ed S. Garratini and M.N.G. Dukes), pp 301–310. Excerpta Med. Internat. Congr. Ser. No. 122 (1967)

  13. Harris, P. A., Riegelman, S.: Influence of the route of administration on the area under the plasma concentration time curve. J. pharm. Sci.58, 71–75 (1969)

    Google Scholar 

  14. Perrier, D., Gibaldi, M.: Clearance and biological half-life as indices of intrinsic hepatic metabolism. J. Pharmacol. exp. Ther.191, 17–24 (1974)

    Google Scholar 

  15. Riegelman, S.: Physiological and pharmacokinetic complexities in bioavailability testing. Pharmacology8, 118–141 (1972)

    Google Scholar 

  16. Rowland, M.: Influence of route of administration on drug availability. J. pharm. Sci.61, 70–74 (1972)

    Google Scholar 

  17. Shand, D. G., Nuckolls, M. S., Oates, J. A.: Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther.11, 112–120 (1970)

    Google Scholar 

  18. Strandell, T., Erwald, R., Kulling, K. G., Lundberg, P., Marions, O., Wiechel, K. L.: Simultaneous determination of portal vein and hepatic artery blood flow by indicator dilution technique in awake man. Preliminary report. Acta med. scand.191, 139–140 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alván, G., Borgå, O., Lind, M. et al. First pass hydroxylation of nortriptyline: Concentrations of parent drug and major metabolites in plasma. Eur J Clin Pharmacol 11, 219–224 (1977). https://doi.org/10.1007/BF00606414

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606414

Key words

Navigation